Eva Medvedova, MD

Eva Medvedova is an Assistant Professor of Medicine at Oregon Health & Science University (OHSU) School of Medicine. She specializes in caring for adults with multiple myeloma, essential thrombocytemia and polycythemia vera. Her areas of expertise are cancer, cancer and blood disorders with special focus on general medical oncology, hematology and lymphoma myeloproliferative disorders.

Dr. Medvedova recieved her medical degree from Comenius University, School of Medicine, Bratislava Slovakia followed by residency in internal medicine and fellowship in hematology/oncology from University of Massachusetts Medical School, Worcester, Mass. She is board certified in internal medicine, hematology and medical oncology and is also a member of American Society of Hematology.

Representative Publications:
Pharmacokinetics and Exposure-Response Analyses of Daratumumab in Combination Therapy Regimens for Patients With Multiple Myeloma
Modified Hypercvad Versus Bortezomib-Hypercad in Patients With Relapsed/Refractory Multiple Myeloma
Bortezomib-Based Chemotherapy for Multiple Myeloma Patients Without Comorbid Cardiovascular Disease Shows no Cardiotoxicity
Double Autophagy Stimulation Using Chemotherapy and Mtor Inhibition Combined With Hydroxychloroquine for Autophagy Modulation in Patients With Relapsed or Refractory Multiple Myeloma